Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 263845, 9 pages
http://dx.doi.org/10.1155/2013/263845
Research Article

Investigation of the Protective Effects of Phlorizin on Diabetic Cardiomyopathy in db/db Mice by Quantitative Proteomics

1Key laboratory of Cardiovascular Proteomics, Qi-Lu Hospital of Shandong University, Jinan, Shandong 250012, China
2Department of Geriatrics, Qi-Lu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, Shandong 250012, China

Received 6 November 2012; Revised 7 January 2013; Accepted 8 January 2013

Academic Editor: Subrata Chakrabarti

Copyright © 2013 Qian Cai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Stamler, O. Vaccaro, J. D. Neaton, and D. Wentworth, “Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial,” Diabetes Care, vol. 16, no. 2, pp. 434–444, 1993. View at Google Scholar · View at Scopus
  2. N. Sarwar, P. Gao, S. R. Seshasai et al., “Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies,” The Lancet, vol. 375, no. 9733, pp. 2215–2222, 2010. View at Google Scholar
  3. S. Rubler, J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman, “New type of cardiomyopathy associated with diabetic glomerulosclerosis,” The American Journal of Cardiology, vol. 30, no. 6, pp. 595–602, 1972. View at Google Scholar · View at Scopus
  4. J. K. Boyer, S. Thanigaraj, K. B. Schechtman, and J. E. Pérez, “Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus,” The American Journal of Cardiology, vol. 93, no. 7, pp. 870–875, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. F. S. Fein and E. H. Sonnenblick, “Diabetic cardiomyopathy,” Progress in Cardiovascular Diseases, vol. 27, no. 4, pp. 255–270, 1985. View at Google Scholar
  6. A. Wojdyło, J. Oszmiański, and P. Laskowski, “Polyphenolic compounds and antioxidant activity of new and old apple varieties,” Journal of Agricultural and Food Chemistry, vol. 56, no. 15, pp. 6520–6530, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Ehrenkranz, N. G. Lewis, C. R. Kahn, and J. Roth, “Phlorizin: a review,” Diabetes/Metabolism Research and Reviews, vol. 21, no. 1, pp. 31–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. P. Hummel, M. M. Dickie, and D. L. Coleman, “Diabetes, a new mutation in the mouse,” Science, vol. 153, no. 3740, pp. 1127–1128, 1966. View at Google Scholar · View at Scopus
  9. L. Herberg and D. L. Coleman, “Laboratory animals exhibiting obesity and diabetes syndromes,” Metabolism, vol. 26, no. 1, pp. 59–99, 1977. View at Google Scholar · View at Scopus
  10. J. Hu, J. Qian, O. Borisov et al., “Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine-specific isobaric tags,” Proteomics, vol. 6, no. 15, pp. 4321–4334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. P. L. Ross, Y. N. Huang, J. N. Marchese et al., “Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents,” Molecular and Cellular Proteomics, vol. 3, no. 12, pp. 1154–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Zhao, H. Gao, J. Qiu, W. Lu, and X. Wei, “The molecular mechanism of protective effects of grape seed proanthocyanidin extract on reperfusion arrhythmias in rats in vivo,” Biological and Pharmaceutical Bulletin, vol. 33, no. 5, pp. 759–767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. X. L. Li, B. Y. Li, H. Q. Gao et al., “Proteomics approach to study the mechanism of action of grape seed proanthocyanidin extracts on arterial remodeling in diabetic rats,” International Journal of Molecular Medicine, vol. 25, no. 2, pp. 237–248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. van de Weijer, V. B. Schrauwen-Hinderling, and P. Schrauwen, “Lipotoxicity in type 2 diabetic cardiomyopathy,” Cardiovascular Research, vol. 92, no. 1, pp. 10–18, 2011. View at Publisher · View at Google Scholar
  15. P. K. Battiprolu, T. G. Gillette, Z. V. Wang, S. Lavandero, and J. A. Hill, “Diabetic cardiomyopathy: mechanisms and therapeutic targets,” Drug Discovery Today, vol. 7, no. 2, pp. e135–e143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. G. Duncan, “Mitochondrial dysfunction in diabetic cardiomyopathy,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1351–1359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. An and B. Rodrigues, “Role of changes in cardiac metabolism in development of diabetic cardiomyopathy,” The American Journal of Physiology, Heart and Circulatory Physiology, vol. 291, no. 4, pp. H1489–H1506, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Rezk, G. R Haenen, W. J. F. van der Vijgh, and A. Bast, “The antioxidant activity of phloretin: the disclosure of a new antioxidant pharmacophore in flavonoids,” Biochemical and Biophysical Research Communications, vol. 295, no. 1, pp. 9–13, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Cusi, “The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes,” Current Diabetes Reports, vol. 10, no. 4, pp. 306–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Kankaanpää, H. R. Lehto, J. P. Pärkkä et al., “Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4689–4695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Wende and E. D. Abel, “Lipotoxicity in the heart,” Biochimica et Biophysica Acta, vol. 1801, no. 3, pp. 311–319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. D. Bartels, J. M. Nielsen, L. I. Hellgren, T. Ploug, and L. B. Nielsen, “Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation,” PLoS ONE, vol. 4, no. 4, Article ID e5300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-H. Chang, D.-M. Chang, K.-C. Lin, S.-J. Shin, and Y.-J. Lee, “Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 6, pp. 515–527, 2011. View at Publisher · View at Google Scholar
  24. M. T. Coughlan, D. R. Thorburn, S. A. Penfold et al., “Rage-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes,” Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 742–752, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. F. Zhi, J. B. Prins, and T. H. Marwick, “Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications,” Endocrine Reviews, vol. 25, no. 4, pp. 543–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Saito, M. Kawaguchi, J. Izumida, T. Asakura, K. Maehara, and Y. Maruyama, “Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of type 2 diabetes mellitus in OLETF rats,” Diabetologia, vol. 46, no. 8, pp. 1161–1169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Borbély, L. van Heerebeek, and W. J. Paulus, “Editorial: transcriptional and posttranslational modifications of titin: implications for diastole,” Circulation Research, vol. 104, no. 1, pp. 12–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Ihara and J. A. MacDonald, “The regulation of smooth muscle contractility by zipper-interacting protein kinase,” Canadian Journal of Physiology and Pharmacology, vol. 85, no. 1, pp. 79–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. E. Kamm and J. T. Stull, “Signaling to myosin regulatory light chain in sarcomeres,” Journal of Biological Chemistry, vol. 286, no. 12, pp. 9941–9947, 2011. View at Publisher · View at Google Scholar · View at Scopus